T1	p 81 136	postmenopausal breast cancer survivors with bone loss :
T2	p 381 434	223 postmenopausal breast cancer survivors . Subjects
T3	p 1111 1129	Postmenopausal BCS
T4	i 20 35	weight training
T5	i 227 252	weight training exercises
T6	i 283 294	risedronate
T7	i 311 320	vitamin D
T8	i 666 677	risedronate
T9	i 694 703	vitamin D
T10	i 896 937	strength/weight training ( ST ) exercises
T11	i 1164 1202	exercise plus medication or medication
T12	i 1263 1387	calcium and 400 IU of vitamin D daily and 35 mg of risedronate weekly , and the exercise group additionally had ST exercises
T13	i 2165 2199	Strength/weight training exercises
T14	o 39 77	bone mineral density and bone turnover
T15	o 349 375	bone mineral density ( BMD
T16	o 498 501	BMD
T17	o 718 746	bone mineral density ( BMD )
T18	o 960 970	in BMD and
T19	o 992 1007	bone turnover ;
T20	o 1097 1102	BMD .
T21	o 1375 1387	ST exercises
T22	o 1507 1510	BMD
T23	o 1691 1717	in BMD at the femoral neck
T24	o 1891 1937	changes in BMD and bone turnover with exercise
T25	o 2036 2039	BMD
T26	o 2212 2223	loss of BMD